- Home
- MOGO vs ANEB Comparison
MOGO vs ANEB Comparison
Compare MOGO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- ANEB
- Stock Information
- Founded
- MOGO 2003
- ANEB 2020
- Country
- MOGO Canada
- ANEB United States
- Employees
- MOGO N/A
- ANEB N/A
- Industry
- MOGO
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- ANEB Health Care
- Exchange
- MOGO Nasdaq
- ANEB Nasdaq
- Market Cap
- MOGO 42.5M
- ANEB 111.8M
- IPO Year
- MOGO N/A
- ANEB 2021
- Fundamental
- Price
- MOGO $1.72
- ANEB $2.75
- Analyst Decision
- MOGO Strong Buy
- ANEB Buy
- Analyst Count
- MOGO 1
- ANEB 2
- Target Price
- MOGO $4.00
- ANEB $8.00
- AVG Volume (30 Days)
- MOGO 199.8K
- ANEB 25.7K
- Earning Date
- MOGO 11-10-2025
- ANEB 11-12-2025
- Dividend Yield
- MOGO N/A
- ANEB N/A
- EPS Growth
- MOGO N/A
- ANEB N/A
- EPS
- MOGO 0.12
- ANEB N/A
- Revenue
- MOGO $30,265,570.00
- ANEB N/A
- Revenue This Year
- MOGO $61.97
- ANEB N/A
- Revenue Next Year
- MOGO $6.28
- ANEB N/A
- P/E Ratio
- MOGO $14.23
- ANEB N/A
- Revenue Growth
- MOGO 0.18
- ANEB N/A
- 52 Week Low
- MOGO $0.74
- ANEB $0.80
- 52 Week High
- MOGO $3.83
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- MOGO 40.65
- ANEB 62.06
- Support Level
- MOGO $1.66
- ANEB $2.50
- Resistance Level
- MOGO $1.89
- ANEB $2.76
- Average True Range (ATR)
- MOGO 0.08
- ANEB 0.13
- MACD
- MOGO -0.02
- ANEB 0.04
- Stochastic Oscillator
- MOGO 16.88
- ANEB 79.03
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.